Correlation Between Omeros and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Omeros and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Omeros and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Omeros and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Omeros and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Omeros with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Omeros and Crinetics Pharmaceuticals.
Diversification Opportunities for Omeros and Crinetics Pharmaceuticals
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Omeros and Crinetics is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Omeros is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Omeros are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Omeros i.e., Omeros and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Omeros and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Omeros is expected to generate 1.09 times more return on investment than Crinetics Pharmaceuticals. However, Omeros is 1.09 times more volatile than Crinetics Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 984.00 in Omeros on November 3, 2024 and sell it today you would lose (122.00) from holding Omeros or give up 12.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Omeros vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Omeros |
| Crinetics Pharmaceuticals |
Omeros and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Omeros and Crinetics Pharmaceuticals
The main advantage of trading using opposite Omeros and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Omeros position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Omeros vs. Crinetics Pharmaceuticals | Omeros vs. Enanta Pharmaceuticals | Omeros vs. Amicus Therapeutics | Omeros vs. Connect Biopharma Holdings |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |